Katelynn Madill-Thomsen Selected Research

methoxy-morpholinyl-doxorubicin

1/2022	Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes.
1/2021	Three-month course of intragraft transcriptional changes in kidney allografts with early histological minimal injury - a cohort study.
12/2020	Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts.
1/2020	Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katelynn Madill-Thomsen Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Arteritis 01/2022 - 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Atrophy 01/2021
1	Fibrosis (Cirrhosis) 01/2021

Drug/Important Bio-Agent (IBA)

4	methoxy-morpholinyl-doxorubicinIBA 01/2022 - 01/2020
1	IsoantibodiesIBA 01/2022
1	AntigensIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022